Fulhold Pharma

CarboHydrate Derived Fulvic Acid (CHD-FA) is a novel platform technology that is an active pharmaceutical, broad-based intervention with strong antimicrobial, anti-inflammatory, dermatological and immunological effects. CHD-FA brings all the benefits of fulvic acid without the regulatory, environmental or sustainability-related downsides.

Fulhold Pharma is a global leader in the development of CHD-FA, with a range of trademarked CHD-FA-based OTC, pharmaceutical and cosmetic products on the market. Development is ongoing on all these fronts.  

Biophys continues to work with Fulhold to expand their product range and to advise on clinical development studies.

SHARE

Facebook
X
LinkedIn